BOLD FY 2018 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$134M

Net Income

-$129M

EPS (Diluted)

$-2.93

Cash Flow

Operating Cash Flow

-$108M

Free Cash Flow

-$120M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$473M

Total Liabilities

$30M

Stockholders' Equity

$443M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$134M	-$93M	-44.2%
Net Income	-$129M	-$90M	-42.8%